Sanjay Aneja

Concepts (126)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Radiation Oncology
9
2019
48
3.380
Why?
Brain Neoplasms
3
2019
176
2.030
Why?
Medical Oncology
3
2019
37
1.500
Why?
Artificial Intelligence
4
2019
25
1.480
Why?
Internship and Residency
3
2013
209
1.300
Why?
Career Choice
3
2013
46
1.140
Why?
Melanoma
3
2019
225
0.960
Why?
Neuroimaging
1
2019
13
0.890
Why?
Genomics
2
2019
74
0.890
Why?
Neurology
1
2019
21
0.880
Why?
Neoplasms
3
2017
586
0.830
Why?
Biomarkers, Tumor
1
2019
140
0.810
Why?
Glioblastoma
2
2016
59
0.700
Why?
Prostatic Neoplasms
4
2018
766
0.660
Why?
Humans
23
2019
18498
0.600
Why?
Comparative Effectiveness Research
1
2014
20
0.590
Why?
Health Services Accessibility
2
2012
101
0.590
Why?
Physicians
2
2011
126
0.570
Why?
Brachytherapy
1
2014
77
0.560
Why?
United States
7
2013
1670
0.550
Why?
Radiosurgery
1
2014
87
0.550
Why?
Radiotherapy, Adjuvant
1
2013
115
0.540
Why?
Hospitals
1
2013
45
0.530
Why?
Healthcare Disparities
1
2013
48
0.530
Why?
Professional Practice Location
1
2011
6
0.520
Why?
Geographic Information Systems
1
2011
5
0.510
Why?
Health Care Costs
1
2012
91
0.500
Why?
Neurosurgical Procedures
1
2013
149
0.490
Why?
Cardiology
1
2011
71
0.490
Why?
Magnetic Resonance Imaging
3
2019
814
0.440
Why?
Aged
9
2018
4472
0.340
Why?
Socioeconomic Factors
3
2017
159
0.290
Why?
Male
10
2018
8838
0.290
Why?
Multimodal Imaging
2
2018
8
0.250
Why?
Regression Analysis
2
2011
149
0.240
Why?
Forecasting
2
2018
111
0.240
Why?
Biomarkers
2
2019
111
0.240
Why?
Skin Neoplasms
2
2012
208
0.220
Why?
Ultrasonography
2
2018
217
0.210
Why?
Computational Biology
1
2019
137
0.190
Why?
Lymphatic Metastasis
1
2018
172
0.190
Why?
Female
7
2018
9489
0.190
Why?
Industry
1
2017
1
0.190
Why?
Clinical Trials, Phase III as Topic
1
2017
19
0.190
Why?
Cancer Care Facilities
1
2017
15
0.190
Why?
Financing, Government
1
2017
10
0.190
Why?
Mycosis Fungoides
1
2017
14
0.190
Why?
Sezary Syndrome
1
2017
17
0.190
Why?
Hospitals, University
1
2017
58
0.190
Why?
Inpatients
1
2017
34
0.180
Why?
Head and Neck Neoplasms
1
2018
164
0.180
Why?
Diagnostic Imaging
1
2018
181
0.180
Why?
Adult
6
2018
5656
0.170
Why?
Radiotherapy
2
2017
91
0.170
Why?
Randomized Controlled Trials as Topic
1
2017
233
0.170
Why?
Middle Aged
6
2018
5845
0.170
Why?
Aged, 80 and over
3
2017
1795
0.160
Why?
Retrospective Studies
3
2018
1787
0.150
Why?
Tomography, X-Ray Computed
1
2018
673
0.150
Why?
Incidence
2
2012
360
0.150
Why?
School Admission Criteria
1
2013
8
0.140
Why?
SEER Program
1
2013
71
0.140
Why?
Computer-Assisted Instruction
1
2012
17
0.140
Why?
Patient Education as Topic
1
2012
110
0.130
Why?
Dermatology
1
2012
18
0.130
Why?
Rural Health Services
1
2011
14
0.130
Why?
Combined Modality Therapy
3
2017
346
0.130
Why?
General Practice
1
2011
1
0.120
Why?
General Practitioners
1
2011
5
0.120
Why?
Demography
1
2011
27
0.120
Why?
Practice Patterns, Physicians'
1
2011
52
0.120
Why?
Software
1
2011
100
0.120
Why?
Minority Groups
1
2011
15
0.120
Why?
Clinical Trials as Topic
1
2012
265
0.120
Why?
Biomedical Research
1
2011
93
0.120
Why?
Lung Neoplasms
1
2014
341
0.110
Why?
Primary Health Care
1
2011
137
0.110
Why?
Quality of Life
1
2012
308
0.110
Why?
Young Adult
1
2013
1112
0.110
Why?
Lymphocyte Count
1
2008
23
0.100
Why?
Acute Coronary Syndrome
1
2008
25
0.100
Why?
Neutrophils
1
2008
51
0.100
Why?
Image-Guided Biopsy
2
2018
9
0.100
Why?
Adolescent
1
2013
1724
0.100
Why?
Neoplasm Grading
2
2018
47
0.100
Why?
Hospital Mortality
1
2008
112
0.090
Why?
Breast Neoplasms
1
2014
862
0.090
Why?
Follow-Up Studies
3
2017
855
0.090
Why?
Prospective Studies
2
2018
855
0.080
Why?
Risk Factors
2
2017
1115
0.060
Why?
Multivariate Analysis
2
2012
288
0.050
Why?
Clinical Decision-Making
1
2018
17
0.050
Why?
Machine Learning
1
2018
3
0.050
Why?
ROC Curve
1
2018
98
0.050
Why?
Patient Care
1
2018
21
0.050
Why?
Decision Support Techniques
1
2018
36
0.050
Why?
False Positive Reactions
1
2018
33
0.050
Why?
Radiotherapy Dosage
1
2018
162
0.050
Why?
Public Health Surveillance
1
2017
3
0.050
Why?
Quality Assurance, Health Care
1
2018
85
0.050
Why?
Surgical Procedures, Operative
1
2017
56
0.040
Why?
Decision Making
1
2017
122
0.040
Why?
Molecular Targeted Therapy
1
2017
70
0.040
Why?
Diagnosis, Differential
1
2018
462
0.040
Why?
Neoplasm Recurrence, Local
1
2018
312
0.040
Why?
Chemoradiotherapy
1
2016
29
0.040
Why?
Survival Rate
1
2017
391
0.040
Why?
Radiology
1
2018
175
0.040
Why?
Sensitivity and Specificity
1
2017
555
0.040
Why?
Prognosis
1
2018
798
0.040
Why?
Odds Ratio
1
2016
148
0.040
Why?
Proportional Hazards Models
1
2016
194
0.040
Why?
Neoplasm Staging
1
2017
476
0.040
Why?
Comorbidity
1
2016
234
0.040
Why?
Biopsy
1
2016
254
0.040
Why?
Risk Assessment
1
2017
540
0.040
Why?
Algorithms
1
2017
380
0.040
Why?
Antineoplastic Agents
1
2017
490
0.030
Why?
Sunscreening Agents
1
2012
2
0.030
Why?
Protective Clothing
1
2012
3
0.030
Why?
Logistic Models
1
2012
282
0.030
Why?
Treatment Outcome
1
2016
2076
0.030
Why?
Patient Admission
1
2008
38
0.020
Why?
Hemorrhage
1
2008
69
0.020
Why?
Recurrence
1
2008
259
0.020
Why?
Stroke
1
2008
225
0.020
Why?
Aneja's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (126)
Explore
_
Co-Authors (1)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_